LU76092A1 - - Google Patents

Info

Publication number
LU76092A1
LU76092A1 LU76092A LU76092A LU76092A1 LU 76092 A1 LU76092 A1 LU 76092A1 LU 76092 A LU76092 A LU 76092A LU 76092 A LU76092 A LU 76092A LU 76092 A1 LU76092 A1 LU 76092A1
Authority
LU
Luxembourg
Application number
LU76092A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/704,142 external-priority patent/US4118491A/en
Application filed filed Critical
Publication of LU76092A1 publication Critical patent/LU76092A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU76092A 1975-10-30 1976-10-28 LU76092A1 (mo)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62716475A 1975-10-30 1975-10-30
US66583776A 1976-03-11 1976-03-11
US05/704,142 US4118491A (en) 1976-03-11 1976-07-12 7-Acyl-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them

Publications (1)

Publication Number Publication Date
LU76092A1 true LU76092A1 (mo) 1977-05-17

Family

ID=27417417

Family Applications (1)

Application Number Title Priority Date Filing Date
LU76092A LU76092A1 (mo) 1975-10-30 1976-10-28

Country Status (17)

Country Link
JP (1) JPS6053026B2 (mo)
AT (1) AT353957B (mo)
AU (1) AU505141B2 (mo)
CA (1) CA1071188A (mo)
CH (1) CH627757A5 (mo)
DE (1) DE2649545A1 (mo)
DK (1) DK463176A (mo)
ES (1) ES452769A1 (mo)
FI (1) FI60868C (mo)
FR (3) FR2361896A1 (mo)
GB (3) GB1570095A (mo)
GR (1) GR61667B (mo)
IE (1) IE44393B1 (mo)
IL (3) IL50546A (mo)
LU (1) LU76092A1 (mo)
NL (1) NL7612010A (mo)
SE (3) SE435291B (mo)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117123A (en) * 1977-06-09 1978-09-26 Smithkline Corporation 7-Acylamino-3-[1-(2-sulfamidoethyl)tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
AT383811B (de) * 1983-09-22 1987-08-25 Biochemie Gmbh Verfahren zur herstellung von monoalkalisalzen von 7-amino-3-cephem-4-carbonsaeurederivaten
US4717531A (en) * 1983-09-23 1988-01-05 Westinghouse Electric Corp. Fuel transfer system upender using translation drive

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207752A1 (es) * 1973-03-30 1976-10-29 Fujisawa Pharmaceutical Co Procedimiento para obtener acidos 7-amino-sustituido-3-tiometilsustituido-3-cefem-4-carboxilicos
US4110338A (en) * 1973-10-31 1978-08-29 Fujisawa Pharmaceutical Co., Ltd. Product and preparation of 1H-tetrazole-5-thiol derivatives
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid

Also Published As

Publication number Publication date
SE435291B (sv) 1984-09-17
JPS5257191A (en) 1977-05-11
GB1570095A (en) 1980-06-25
FR2351982B1 (mo) 1981-07-03
JPS6053026B2 (ja) 1985-11-22
FR2351982A1 (fr) 1977-12-16
AT353957B (de) 1979-12-10
SE452621B (sv) 1987-12-07
FR2361896B1 (mo) 1979-02-23
DK463176A (da) 1977-05-01
GR61667B (en) 1978-12-05
DE2649545A1 (de) 1977-05-12
FR2361896A1 (fr) 1978-03-17
IL56757A0 (en) 1979-05-31
FI60868C (fi) 1982-04-13
FI60868B (fi) 1981-12-31
IL50546A (en) 1980-07-31
IL56758A0 (en) 1979-05-31
SE8006413L (sv) 1980-09-12
CA1071188A (en) 1980-02-05
CH627757A5 (en) 1982-01-29
AU505141B2 (en) 1979-11-08
ATA807276A (de) 1979-05-15
SE8006414L (sv) 1980-09-12
SE7610722L (sv) 1977-05-01
GB1570093A (en) 1980-06-25
IE44393L (en) 1977-09-11
SE437025B (sv) 1985-02-04
AU1870276A (en) 1978-04-20
NL7612010A (nl) 1977-05-03
GB1570094A (en) 1980-06-25
FR2337720B1 (mo) 1981-07-10
ES452769A1 (es) 1978-01-16
FI763044A7 (mo) 1977-05-01
IE44393B1 (en) 1981-11-18
IL50546A0 (en) 1976-11-30
FR2337720A1 (fr) 1977-08-05

Similar Documents

Publication Publication Date Title
JPS5279487U (mo)
JPS553603B2 (mo)
FR2337720B1 (mo)
JPS5237427U (mo)
JPS5527013Y2 (mo)
JPS5196774U (mo)
JPS5226663U (mo)
JPS51148484U (mo)
CH600357A5 (mo)
CH603263A5 (mo)
BG21749A1 (mo)
CH602135A5 (mo)
CH596119A5 (mo)
CH597750A5 (mo)
CH599485B5 (mo)
CH602120A5 (mo)
BG21768A1 (mo)
BG22565A1 (mo)
CH603493A5 (mo)
CH597501A5 (mo)
CH591648A5 (mo)
CH601833A5 (mo)
CH604187A5 (mo)
CH606606A5 (mo)
CH604059A5 (mo)